Ngwenya, T., & Barth, S. (2024). Development Of Recombinant Immunotherapeutics for Triple-Negative Breast Cancer (TNBC). Institute of Infectious Disease and Molecular Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Ngwenya, Takunda, and Stefan Barth. Development Of Recombinant Immunotherapeutics for Triple-Negative Breast Cancer (TNBC). Institute of Infectious Disease and Molecular Medicine, 2024.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Ngwenya, Takunda, and Stefan Barth. Development Of Recombinant Immunotherapeutics for Triple-Negative Breast Cancer (TNBC). Institute of Infectious Disease and Molecular Medicine, 2024.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.